Deterioration of biventricular strain is an early marker of cardiac involvement in confirmed sarcoidosis

Eur Heart J Cardiovasc Imaging. 2020 Jul 1;21(7):796-804. doi: 10.1093/ehjci/jez235.

Abstract

Aims: Risk assessment of developing cardiac involvement in systemic sarcoidosis can be challenging because of limited data. Recently, attention has been given to left ventricular and right ventricular (LV and RV) involvement in cardiac sarcoidosis (CS) and its prevalence, relevance, and prognostic value. The aim of this study was to assess the role of biventricular strain to predict prognosis in confirmed sarcoidosis patients.

Methods and results: LV and RV longitudinal strains (LSs) were evaluated by 2D speckle tracking in 139 consecutive confirmed sarcoidosis patients without other pre-existing structural heart diseases, and 52 age- and gender-matched control subjects. The primary endpoint was CS-related events (cardiac death or development of cardiac involvement). Sarcoidosis without cardiac involvement had significantly lower LV and RV free wall LS compared with control subjects. Basal LS had a higher area under the curve for differentiation of sarcoidosis in patients without cardiac involvement compared to control (cut-off value: -18% with 89% sensitivity and 69% specificity). During a median period of 50 months, the occurrence of CS-related events was observed in 20 patients. In a multivariate analysis, basal LV LS and RV free wall LS were associated with the events [hazard ratio (HR) 0.72, P < 0.001 and HR: 0.83, P = 0.006, respectively]. Patients with impaired biventricular function had significantly shorter event-free survival than those with preserved biventricular function (P < 0.001).

Conclusion: Deterioration of biventricular strain was associated with CS-related events. This information might be useful for clinical evaluation and follow-up in sarcoidosis.

Keywords: cardiac sarcoidosis; echocardiography; left ventricular strains; right ventricular function; strain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Heart Ventricles
  • Humans
  • Prognosis
  • Proportional Hazards Models
  • Risk Assessment
  • Sarcoidosis* / diagnostic imaging